nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—SLCO1B1—breast cancer	0.191	0.545	CbGaD
Ezetimibe—ABCG2—breast cancer	0.083	0.237	CbGaD
Ezetimibe—CYP3A4—breast cancer	0.0415	0.119	CbGaD
Ezetimibe—ABCB1—breast cancer	0.0345	0.0988	CbGaD
Ezetimibe—ABCC3—Fluorouracil—breast cancer	0.021	0.057	CbGbCtD
Ezetimibe—UGT2B7—Epirubicin—breast cancer	0.0195	0.0527	CbGbCtD
Ezetimibe—UGT1A1—Irinotecan—breast cancer	0.0164	0.0443	CbGbCtD
Ezetimibe—ABCC2—Tamoxifen—breast cancer	0.013	0.0351	CbGbCtD
Ezetimibe—ABCC3—Doxorubicin—breast cancer	0.012	0.0324	CbGbCtD
Ezetimibe—ABCG2—Tamoxifen—breast cancer	0.0117	0.0318	CbGbCtD
Ezetimibe—ABCC3—Methotrexate—breast cancer	0.0116	0.0314	CbGbCtD
Ezetimibe—ABCB1—Toremifene—breast cancer	0.0116	0.0313	CbGbCtD
Ezetimibe—ABCG2—Mitoxantrone—breast cancer	0.0114	0.031	CbGbCtD
Ezetimibe—SLCO1B1—Irinotecan—breast cancer	0.0113	0.0307	CbGbCtD
Ezetimibe—ABCC2—Paclitaxel—breast cancer	0.0101	0.0273	CbGbCtD
Ezetimibe—CYP3A4—Exemestane—breast cancer	0.01	0.0271	CbGbCtD
Ezetimibe—ABCC2—Irinotecan—breast cancer	0.00996	0.027	CbGbCtD
Ezetimibe—ABCC2—Carboplatin—breast cancer	0.0095	0.0257	CbGbCtD
Ezetimibe—ABCG2—Paclitaxel—breast cancer	0.00913	0.0247	CbGbCtD
Ezetimibe—ABCG2—Irinotecan—breast cancer	0.009	0.0244	CbGbCtD
Ezetimibe—ABCC2—Vinblastine—breast cancer	0.00885	0.024	CbGbCtD
Ezetimibe—ABCG2—Fluorouracil—breast cancer	0.00864	0.0234	CbGbCtD
Ezetimibe—ABCG2—Carboplatin—breast cancer	0.00859	0.0233	CbGbCtD
Ezetimibe—CYP3A4—Letrozole—breast cancer	0.00851	0.023	CbGbCtD
Ezetimibe—ABCB1—Lapatinib—breast cancer	0.00844	0.0229	CbGbCtD
Ezetimibe—CYP3A4—Anastrozole—breast cancer	0.00758	0.0205	CbGbCtD
Ezetimibe—ABCC2—Docetaxel—breast cancer	0.0073	0.0198	CbGbCtD
Ezetimibe—CYP3A4—Toremifene—breast cancer	0.00693	0.0188	CbGbCtD
Ezetimibe—ABCG2—Docetaxel—breast cancer	0.0066	0.0179	CbGbCtD
Ezetimibe—CYP3A4—Fulvestrant—breast cancer	0.00645	0.0175	CbGbCtD
Ezetimibe—SLCO1B1—Methotrexate—breast cancer	0.006	0.0162	CbGbCtD
Ezetimibe—CYP3A4—Thiotepa—breast cancer	0.00575	0.0156	CbGbCtD
Ezetimibe—ABCC2—Doxorubicin—breast cancer	0.00544	0.0147	CbGbCtD
Ezetimibe—ABCC2—Methotrexate—breast cancer	0.00527	0.0143	CbGbCtD
Ezetimibe—CYP3A4—Ixabepilone—breast cancer	0.00526	0.0142	CbGbCtD
Ezetimibe—CYP3A4—Lapatinib—breast cancer	0.00506	0.0137	CbGbCtD
Ezetimibe—ABCG2—Doxorubicin—breast cancer	0.00492	0.0133	CbGbCtD
Ezetimibe—ABCG2—Methotrexate—breast cancer	0.00476	0.0129	CbGbCtD
Ezetimibe—ABCB1—Vinorelbine—breast cancer	0.00468	0.0127	CbGbCtD
Ezetimibe—ABCB1—Tamoxifen—breast cancer	0.00423	0.0115	CbGbCtD
Ezetimibe—ABCB1—Mitoxantrone—breast cancer	0.00412	0.0112	CbGbCtD
Ezetimibe—CYP3A4—Raloxifene—breast cancer	0.00383	0.0104	CbGbCtD
Ezetimibe—ABCB1—Gemcitabine—breast cancer	0.00364	0.00987	CbGbCtD
Ezetimibe—ABCB1—Paclitaxel—breast cancer	0.00329	0.00891	CbGbCtD
Ezetimibe—ABCB1—Irinotecan—breast cancer	0.00325	0.00879	CbGbCtD
Ezetimibe—ABCB1—Vinblastine—breast cancer	0.00289	0.00782	CbGbCtD
Ezetimibe—CYP3A4—Vinorelbine—breast cancer	0.00281	0.0076	CbGbCtD
Ezetimibe—CYP3A4—Tamoxifen—breast cancer	0.00253	0.00686	CbGbCtD
Ezetimibe—CYP3A4—Mitoxantrone—breast cancer	0.00247	0.00669	CbGbCtD
Ezetimibe—ABCB1—Docetaxel—breast cancer	0.00238	0.00644	CbGbCtD
Ezetimibe—UGT2B15—mammary gland—breast cancer	0.00213	0.0521	CbGeAlD
Ezetimibe—ABCG5—endocrine gland—breast cancer	0.00199	0.0488	CbGeAlD
Ezetimibe—CYP3A4—Paclitaxel—breast cancer	0.00197	0.00534	CbGbCtD
Ezetimibe—CYP3A4—Irinotecan—breast cancer	0.00194	0.00527	CbGbCtD
Ezetimibe—NPC1L1—endocrine gland—breast cancer	0.00188	0.0459	CbGeAlD
Ezetimibe—ABCG8—endocrine gland—breast cancer	0.00178	0.0435	CbGeAlD
Ezetimibe—ABCB1—Doxorubicin—breast cancer	0.00177	0.0048	CbGbCtD
Ezetimibe—ANPEP—mammary gland—breast cancer	0.00175	0.0429	CbGeAlD
Ezetimibe—CYP3A4—Vinblastine—breast cancer	0.00173	0.00468	CbGbCtD
Ezetimibe—ABCB1—Methotrexate—breast cancer	0.00172	0.00465	CbGbCtD
Ezetimibe—SOAT1—nipple—breast cancer	0.00152	0.0371	CbGeAlD
Ezetimibe—ANPEP—nipple—breast cancer	0.00145	0.0355	CbGeAlD
Ezetimibe—CYP3A4—Docetaxel—breast cancer	0.00143	0.00386	CbGbCtD
Ezetimibe—ANPEP—embryo—breast cancer	0.0012	0.0293	CbGeAlD
Ezetimibe—CYP3A4—Doxorubicin—breast cancer	0.00106	0.00288	CbGbCtD
Ezetimibe—ANPEP—epithelium—breast cancer	0.000977	0.0239	CbGeAlD
Ezetimibe—ANPEP—skin of body—breast cancer	0.000929	0.0227	CbGeAlD
Ezetimibe—SLCO1B1—mammary gland—breast cancer	0.000922	0.0225	CbGeAlD
Ezetimibe—SOAT1—endometrium—breast cancer	0.000916	0.0224	CbGeAlD
Ezetimibe—UGT2B15—female reproductive system—breast cancer	0.000882	0.0216	CbGeAlD
Ezetimibe—ANPEP—endometrium—breast cancer	0.000876	0.0214	CbGeAlD
Ezetimibe—SOAT1—pituitary gland—breast cancer	0.000829	0.0203	CbGeAlD
Ezetimibe—SOAT1—adipose tissue—breast cancer	0.000826	0.0202	CbGeAlD
Ezetimibe—ANPEP—uterus—breast cancer	0.000807	0.0197	CbGeAlD
Ezetimibe—UGT1A3—endocrine gland—breast cancer	0.000794	0.0194	CbGeAlD
Ezetimibe—ANPEP—pituitary gland—breast cancer	0.000793	0.0194	CbGeAlD
Ezetimibe—ANPEP—adipose tissue—breast cancer	0.00079	0.0193	CbGeAlD
Ezetimibe—SOAT1—female reproductive system—breast cancer	0.000759	0.0186	CbGeAlD
Ezetimibe—UGT2B15—endocrine gland—breast cancer	0.000747	0.0183	CbGeAlD
Ezetimibe—SOAT1—adrenal gland—breast cancer	0.000741	0.0181	CbGeAlD
Ezetimibe—ANPEP—female reproductive system—breast cancer	0.000726	0.0178	CbGeAlD
Ezetimibe—SOAT1—bone marrow—breast cancer	0.000716	0.0175	CbGeAlD
Ezetimibe—ANPEP—adrenal gland—breast cancer	0.000708	0.0173	CbGeAlD
Ezetimibe—SOAT1—female gonad—breast cancer	0.000691	0.0169	CbGeAlD
Ezetimibe—ANPEP—bone marrow—breast cancer	0.000685	0.0168	CbGeAlD
Ezetimibe—ANPEP—female gonad—breast cancer	0.00066	0.0162	CbGeAlD
Ezetimibe—SOAT1—endocrine gland—breast cancer	0.000642	0.0157	CbGeAlD
Ezetimibe—ANPEP—endocrine gland—breast cancer	0.000614	0.015	CbGeAlD
Ezetimibe—UGT2B7—female reproductive system—breast cancer	0.000539	0.0132	CbGeAlD
Ezetimibe—UGT2B7—endocrine gland—breast cancer	0.000456	0.0112	CbGeAlD
Ezetimibe—SOAT1—lymph node—breast cancer	0.000444	0.0109	CbGeAlD
Ezetimibe—ANPEP—lymph node—breast cancer	0.000425	0.0104	CbGeAlD
Ezetimibe—ABCC3—adipose tissue—breast cancer	0.000394	0.00963	CbGeAlD
Ezetimibe—UGT1A1—endocrine gland—breast cancer	0.000388	0.00948	CbGeAlD
Ezetimibe—SLCO1B1—female reproductive system—breast cancer	0.000381	0.00932	CbGeAlD
Ezetimibe—ABCC3—female reproductive system—breast cancer	0.000362	0.00885	CbGeAlD
Ezetimibe—ABCC3—adrenal gland—breast cancer	0.000353	0.00863	CbGeAlD
Ezetimibe—ABCC3—female gonad—breast cancer	0.000329	0.00805	CbGeAlD
Ezetimibe—SLCO1B1—endocrine gland—breast cancer	0.000323	0.00789	CbGeAlD
Ezetimibe—ABCC3—endocrine gland—breast cancer	0.000306	0.00749	CbGeAlD
Ezetimibe—ABCC2—female reproductive system—breast cancer	0.000289	0.00707	CbGeAlD
Ezetimibe—ABCC2—adrenal gland—breast cancer	0.000282	0.0069	CbGeAlD
Ezetimibe—ABCG2—endometrium—breast cancer	0.000254	0.00622	CbGeAlD
Ezetimibe—ABCC2—endocrine gland—breast cancer	0.000245	0.00598	CbGeAlD
Ezetimibe—ABCG2—uterus—breast cancer	0.000234	0.00573	CbGeAlD
Ezetimibe—ABCG2—pituitary gland—breast cancer	0.00023	0.00563	CbGeAlD
Ezetimibe—ABCG2—adipose tissue—breast cancer	0.000229	0.00561	CbGeAlD
Ezetimibe—ABCC3—lymph node—breast cancer	0.000212	0.00518	CbGeAlD
Ezetimibe—ABCG2—adrenal gland—breast cancer	0.000206	0.00503	CbGeAlD
Ezetimibe—ABCG2—bone marrow—breast cancer	0.000199	0.00487	CbGeAlD
Ezetimibe—ABCG2—female gonad—breast cancer	0.000192	0.00469	CbGeAlD
Ezetimibe—ABCB1—embryo—breast cancer	0.000171	0.00419	CbGeAlD
Ezetimibe—ABCC2—lymph node—breast cancer	0.000169	0.00414	CbGeAlD
Ezetimibe—Flunarizine—CYP1A1—breast cancer	0.000168	0.285	CrCbGaD
Ezetimibe—CYP3A4—female reproductive system—breast cancer	0.000147	0.00359	CbGeAlD
Ezetimibe—ABCB1—epithelium—breast cancer	0.00014	0.00342	CbGeAlD
Ezetimibe—ABCB1—endometrium—breast cancer	0.000125	0.00307	CbGeAlD
Ezetimibe—Flunarizine—CYP2D6—breast cancer	0.000125	0.212	CrCbGaD
Ezetimibe—CYP3A4—endocrine gland—breast cancer	0.000124	0.00304	CbGeAlD
Ezetimibe—ABCG2—lymph node—breast cancer	0.000123	0.00302	CbGeAlD
Ezetimibe—ABCB1—uterus—breast cancer	0.000116	0.00283	CbGeAlD
Ezetimibe—Pimozide—CYP2D6—breast cancer	0.000115	0.196	CrCbGaD
Ezetimibe—ABCB1—pituitary gland—breast cancer	0.000114	0.00278	CbGeAlD
Ezetimibe—ABCB1—adipose tissue—breast cancer	0.000113	0.00277	CbGeAlD
Ezetimibe—ABCB1—female reproductive system—breast cancer	0.000104	0.00254	CbGeAlD
Ezetimibe—ABCB1—adrenal gland—breast cancer	0.000101	0.00248	CbGeAlD
Ezetimibe—Pimozide—CYP3A4—breast cancer	9.88e-05	0.168	CrCbGaD
Ezetimibe—ABCB1—bone marrow—breast cancer	9.81e-05	0.0024	CbGeAlD
Ezetimibe—ABCB1—female gonad—breast cancer	9.46e-05	0.00231	CbGeAlD
Ezetimibe—ABCB1—endocrine gland—breast cancer	8.8e-05	0.00215	CbGeAlD
Ezetimibe—Pimozide—ABCB1—breast cancer	8.23e-05	0.14	CrCbGaD
Ezetimibe—ABCB1—lymph node—breast cancer	6.08e-05	0.00149	CbGeAlD
Ezetimibe—Pharyngitis—Epirubicin—breast cancer	3.33e-05	0.000249	CcSEcCtD
Ezetimibe—Skin disorder—Capecitabine—breast cancer	3.33e-05	0.000249	CcSEcCtD
Ezetimibe—Urticaria—Paclitaxel—breast cancer	3.31e-05	0.000248	CcSEcCtD
Ezetimibe—Oedema peripheral—Epirubicin—breast cancer	3.31e-05	0.000247	CcSEcCtD
Ezetimibe—Connective tissue disorder—Epirubicin—breast cancer	3.3e-05	0.000247	CcSEcCtD
Ezetimibe—Abdominal pain—Paclitaxel—breast cancer	3.3e-05	0.000247	CcSEcCtD
Ezetimibe—Body temperature increased—Paclitaxel—breast cancer	3.3e-05	0.000247	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Doxorubicin—breast cancer	3.27e-05	0.000245	CcSEcCtD
Ezetimibe—Angiopathy—Methotrexate—breast cancer	3.26e-05	0.000243	CcSEcCtD
Ezetimibe—Vomiting—Mitoxantrone—breast cancer	3.25e-05	0.000243	CcSEcCtD
Ezetimibe—Vomiting—Irinotecan—breast cancer	3.25e-05	0.000243	CcSEcCtD
Ezetimibe—Sinusitis—Doxorubicin—breast cancer	3.25e-05	0.000243	CcSEcCtD
Ezetimibe—Immune system disorder—Methotrexate—breast cancer	3.24e-05	0.000242	CcSEcCtD
Ezetimibe—Dizziness—Fluorouracil—breast cancer	3.24e-05	0.000242	CcSEcCtD
Ezetimibe—Mediastinal disorder—Methotrexate—breast cancer	3.23e-05	0.000242	CcSEcCtD
Ezetimibe—Rash—Irinotecan—breast cancer	3.23e-05	0.000241	CcSEcCtD
Ezetimibe—Rash—Mitoxantrone—breast cancer	3.23e-05	0.000241	CcSEcCtD
Ezetimibe—Dermatitis—Irinotecan—breast cancer	3.22e-05	0.000241	CcSEcCtD
Ezetimibe—Dermatitis—Mitoxantrone—breast cancer	3.22e-05	0.000241	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Docetaxel—breast cancer	3.22e-05	0.000241	CcSEcCtD
Ezetimibe—Headache—Irinotecan—breast cancer	3.21e-05	0.00024	CcSEcCtD
Ezetimibe—Headache—Mitoxantrone—breast cancer	3.21e-05	0.00024	CcSEcCtD
Ezetimibe—Insomnia—Docetaxel—breast cancer	3.2e-05	0.000239	CcSEcCtD
Ezetimibe—Paraesthesia—Docetaxel—breast cancer	3.18e-05	0.000237	CcSEcCtD
Ezetimibe—Erythema multiforme—Epirubicin—breast cancer	3.17e-05	0.000237	CcSEcCtD
Ezetimibe—Alopecia—Methotrexate—breast cancer	3.17e-05	0.000237	CcSEcCtD
Ezetimibe—Vomiting—Gemcitabine—breast cancer	3.17e-05	0.000237	CcSEcCtD
Ezetimibe—Dyspnoea—Docetaxel—breast cancer	3.15e-05	0.000236	CcSEcCtD
Ezetimibe—Mental disorder—Methotrexate—breast cancer	3.14e-05	0.000235	CcSEcCtD
Ezetimibe—Rash—Gemcitabine—breast cancer	3.14e-05	0.000235	CcSEcCtD
Ezetimibe—Dermatitis—Gemcitabine—breast cancer	3.14e-05	0.000235	CcSEcCtD
Ezetimibe—Malnutrition—Methotrexate—breast cancer	3.12e-05	0.000234	CcSEcCtD
Ezetimibe—Erythema—Methotrexate—breast cancer	3.12e-05	0.000234	CcSEcCtD
Ezetimibe—Headache—Gemcitabine—breast cancer	3.12e-05	0.000233	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Capecitabine—breast cancer	3.12e-05	0.000233	CcSEcCtD
Ezetimibe—Flushing—Epirubicin—breast cancer	3.12e-05	0.000233	CcSEcCtD
Ezetimibe—Vomiting—Fluorouracil—breast cancer	3.12e-05	0.000233	CcSEcCtD
Ezetimibe—Dyspepsia—Docetaxel—breast cancer	3.11e-05	0.000233	CcSEcCtD
Ezetimibe—Hepatitis—Doxorubicin—breast cancer	3.11e-05	0.000232	CcSEcCtD
Ezetimibe—Insomnia—Capecitabine—breast cancer	3.1e-05	0.000232	CcSEcCtD
Ezetimibe—Rash—Fluorouracil—breast cancer	3.09e-05	0.000231	CcSEcCtD
Ezetimibe—Dermatitis—Fluorouracil—breast cancer	3.09e-05	0.000231	CcSEcCtD
Ezetimibe—Pharyngitis—Doxorubicin—breast cancer	3.08e-05	0.000231	CcSEcCtD
Ezetimibe—Paraesthesia—Capecitabine—breast cancer	3.07e-05	0.00023	CcSEcCtD
Ezetimibe—Decreased appetite—Docetaxel—breast cancer	3.07e-05	0.00023	CcSEcCtD
Ezetimibe—Hypersensitivity—Paclitaxel—breast cancer	3.07e-05	0.00023	CcSEcCtD
Ezetimibe—Headache—Fluorouracil—breast cancer	3.07e-05	0.00023	CcSEcCtD
Ezetimibe—Oedema peripheral—Doxorubicin—breast cancer	3.06e-05	0.000229	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Docetaxel—breast cancer	3.05e-05	0.000228	CcSEcCtD
Ezetimibe—Connective tissue disorder—Doxorubicin—breast cancer	3.05e-05	0.000228	CcSEcCtD
Ezetimibe—Dyspnoea—Capecitabine—breast cancer	3.05e-05	0.000228	CcSEcCtD
Ezetimibe—Fatigue—Docetaxel—breast cancer	3.05e-05	0.000228	CcSEcCtD
Ezetimibe—Angiopathy—Epirubicin—breast cancer	3.05e-05	0.000228	CcSEcCtD
Ezetimibe—Nausea—Irinotecan—breast cancer	3.04e-05	0.000227	CcSEcCtD
Ezetimibe—Nausea—Mitoxantrone—breast cancer	3.04e-05	0.000227	CcSEcCtD
Ezetimibe—Immune system disorder—Epirubicin—breast cancer	3.03e-05	0.000227	CcSEcCtD
Ezetimibe—Mediastinal disorder—Epirubicin—breast cancer	3.03e-05	0.000226	CcSEcCtD
Ezetimibe—Constipation—Docetaxel—breast cancer	3.02e-05	0.000226	CcSEcCtD
Ezetimibe—Pain—Docetaxel—breast cancer	3.02e-05	0.000226	CcSEcCtD
Ezetimibe—Back pain—Methotrexate—breast cancer	3.02e-05	0.000226	CcSEcCtD
Ezetimibe—Dyspepsia—Capecitabine—breast cancer	3.01e-05	0.000225	CcSEcCtD
Ezetimibe—Asthenia—Paclitaxel—breast cancer	2.99e-05	0.000224	CcSEcCtD
Ezetimibe—Decreased appetite—Capecitabine—breast cancer	2.98e-05	0.000223	CcSEcCtD
Ezetimibe—Alopecia—Epirubicin—breast cancer	2.97e-05	0.000222	CcSEcCtD
Ezetimibe—Nausea—Gemcitabine—breast cancer	2.96e-05	0.000221	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Capecitabine—breast cancer	2.96e-05	0.000221	CcSEcCtD
Ezetimibe—Fatigue—Capecitabine—breast cancer	2.95e-05	0.000221	CcSEcCtD
Ezetimibe—Pruritus—Paclitaxel—breast cancer	2.95e-05	0.000221	CcSEcCtD
Ezetimibe—Mental disorder—Epirubicin—breast cancer	2.94e-05	0.00022	CcSEcCtD
Ezetimibe—Erythema multiforme—Doxorubicin—breast cancer	2.94e-05	0.00022	CcSEcCtD
Ezetimibe—Constipation—Capecitabine—breast cancer	2.93e-05	0.000219	CcSEcCtD
Ezetimibe—Pain—Capecitabine—breast cancer	2.93e-05	0.000219	CcSEcCtD
Ezetimibe—Erythema—Epirubicin—breast cancer	2.92e-05	0.000219	CcSEcCtD
Ezetimibe—Malnutrition—Epirubicin—breast cancer	2.92e-05	0.000219	CcSEcCtD
Ezetimibe—Feeling abnormal—Docetaxel—breast cancer	2.91e-05	0.000218	CcSEcCtD
Ezetimibe—Nausea—Fluorouracil—breast cancer	2.91e-05	0.000218	CcSEcCtD
Ezetimibe—Ill-defined disorder—Methotrexate—breast cancer	2.9e-05	0.000217	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Docetaxel—breast cancer	2.89e-05	0.000216	CcSEcCtD
Ezetimibe—Anaemia—Methotrexate—breast cancer	2.89e-05	0.000216	CcSEcCtD
Ezetimibe—Flushing—Doxorubicin—breast cancer	2.88e-05	0.000216	CcSEcCtD
Ezetimibe—Flatulence—Epirubicin—breast cancer	2.88e-05	0.000215	CcSEcCtD
Ezetimibe—Diarrhoea—Paclitaxel—breast cancer	2.85e-05	0.000213	CcSEcCtD
Ezetimibe—Back pain—Epirubicin—breast cancer	2.83e-05	0.000211	CcSEcCtD
Ezetimibe—Feeling abnormal—Capecitabine—breast cancer	2.82e-05	0.000211	CcSEcCtD
Ezetimibe—Angiopathy—Doxorubicin—breast cancer	2.82e-05	0.000211	CcSEcCtD
Ezetimibe—Malaise—Methotrexate—breast cancer	2.82e-05	0.000211	CcSEcCtD
Ezetimibe—Muscle spasms—Epirubicin—breast cancer	2.81e-05	0.00021	CcSEcCtD
Ezetimibe—Immune system disorder—Doxorubicin—breast cancer	2.81e-05	0.00021	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Capecitabine—breast cancer	2.8e-05	0.000209	CcSEcCtD
Ezetimibe—Mediastinal disorder—Doxorubicin—breast cancer	2.8e-05	0.000209	CcSEcCtD
Ezetimibe—Body temperature increased—Docetaxel—breast cancer	2.8e-05	0.000209	CcSEcCtD
Ezetimibe—Abdominal pain—Docetaxel—breast cancer	2.8e-05	0.000209	CcSEcCtD
Ezetimibe—Dizziness—Paclitaxel—breast cancer	2.76e-05	0.000206	CcSEcCtD
Ezetimibe—Alopecia—Doxorubicin—breast cancer	2.75e-05	0.000205	CcSEcCtD
Ezetimibe—Cough—Methotrexate—breast cancer	2.73e-05	0.000204	CcSEcCtD
Ezetimibe—Mental disorder—Doxorubicin—breast cancer	2.72e-05	0.000204	CcSEcCtD
Ezetimibe—Urticaria—Capecitabine—breast cancer	2.72e-05	0.000203	CcSEcCtD
Ezetimibe—Ill-defined disorder—Epirubicin—breast cancer	2.71e-05	0.000203	CcSEcCtD
Ezetimibe—Abdominal pain—Capecitabine—breast cancer	2.71e-05	0.000202	CcSEcCtD
Ezetimibe—Body temperature increased—Capecitabine—breast cancer	2.71e-05	0.000202	CcSEcCtD
Ezetimibe—Erythema—Doxorubicin—breast cancer	2.7e-05	0.000202	CcSEcCtD
Ezetimibe—Malnutrition—Doxorubicin—breast cancer	2.7e-05	0.000202	CcSEcCtD
Ezetimibe—Anaemia—Epirubicin—breast cancer	2.7e-05	0.000202	CcSEcCtD
Ezetimibe—Flatulence—Doxorubicin—breast cancer	2.67e-05	0.000199	CcSEcCtD
Ezetimibe—Chest pain—Methotrexate—breast cancer	2.66e-05	0.000199	CcSEcCtD
Ezetimibe—Myalgia—Methotrexate—breast cancer	2.66e-05	0.000199	CcSEcCtD
Ezetimibe—Arthralgia—Methotrexate—breast cancer	2.66e-05	0.000199	CcSEcCtD
Ezetimibe—Vomiting—Paclitaxel—breast cancer	2.65e-05	0.000198	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.64e-05	0.000197	CcSEcCtD
Ezetimibe—Malaise—Epirubicin—breast cancer	2.64e-05	0.000197	CcSEcCtD
Ezetimibe—Rash—Paclitaxel—breast cancer	2.63e-05	0.000197	CcSEcCtD
Ezetimibe—Dermatitis—Paclitaxel—breast cancer	2.63e-05	0.000197	CcSEcCtD
Ezetimibe—Discomfort—Methotrexate—breast cancer	2.63e-05	0.000196	CcSEcCtD
Ezetimibe—Back pain—Doxorubicin—breast cancer	2.62e-05	0.000196	CcSEcCtD
Ezetimibe—Headache—Paclitaxel—breast cancer	2.61e-05	0.000195	CcSEcCtD
Ezetimibe—Hypersensitivity—Docetaxel—breast cancer	2.61e-05	0.000195	CcSEcCtD
Ezetimibe—Muscle spasms—Doxorubicin—breast cancer	2.6e-05	0.000194	CcSEcCtD
Ezetimibe—Palpitations—Epirubicin—breast cancer	2.58e-05	0.000193	CcSEcCtD
Ezetimibe—Confusional state—Methotrexate—breast cancer	2.57e-05	0.000192	CcSEcCtD
Ezetimibe—Cough—Epirubicin—breast cancer	2.55e-05	0.000191	CcSEcCtD
Ezetimibe—Anaphylactic shock—Methotrexate—breast cancer	2.55e-05	0.000191	CcSEcCtD
Ezetimibe—Asthenia—Docetaxel—breast cancer	2.54e-05	0.00019	CcSEcCtD
Ezetimibe—Infection—Methotrexate—breast cancer	2.53e-05	0.000189	CcSEcCtD
Ezetimibe—Hypertension—Epirubicin—breast cancer	2.52e-05	0.000189	CcSEcCtD
Ezetimibe—Hypersensitivity—Capecitabine—breast cancer	2.52e-05	0.000189	CcSEcCtD
Ezetimibe—Ill-defined disorder—Doxorubicin—breast cancer	2.51e-05	0.000188	CcSEcCtD
Ezetimibe—Pruritus—Docetaxel—breast cancer	2.5e-05	0.000187	CcSEcCtD
Ezetimibe—Nervous system disorder—Methotrexate—breast cancer	2.5e-05	0.000187	CcSEcCtD
Ezetimibe—Anaemia—Doxorubicin—breast cancer	2.5e-05	0.000187	CcSEcCtD
Ezetimibe—Thrombocytopenia—Methotrexate—breast cancer	2.5e-05	0.000187	CcSEcCtD
Ezetimibe—Chest pain—Epirubicin—breast cancer	2.49e-05	0.000186	CcSEcCtD
Ezetimibe—Arthralgia—Epirubicin—breast cancer	2.49e-05	0.000186	CcSEcCtD
Ezetimibe—Myalgia—Epirubicin—breast cancer	2.49e-05	0.000186	CcSEcCtD
Ezetimibe—Nausea—Paclitaxel—breast cancer	2.48e-05	0.000185	CcSEcCtD
Ezetimibe—Skin disorder—Methotrexate—breast cancer	2.48e-05	0.000185	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.47e-05	0.000185	CcSEcCtD
Ezetimibe—Discomfort—Epirubicin—breast cancer	2.46e-05	0.000184	CcSEcCtD
Ezetimibe—Asthenia—Capecitabine—breast cancer	2.46e-05	0.000184	CcSEcCtD
Ezetimibe—Malaise—Doxorubicin—breast cancer	2.44e-05	0.000182	CcSEcCtD
Ezetimibe—Dry mouth—Epirubicin—breast cancer	2.43e-05	0.000182	CcSEcCtD
Ezetimibe—Pruritus—Capecitabine—breast cancer	2.42e-05	0.000181	CcSEcCtD
Ezetimibe—Diarrhoea—Docetaxel—breast cancer	2.42e-05	0.000181	CcSEcCtD
Ezetimibe—Confusional state—Epirubicin—breast cancer	2.41e-05	0.00018	CcSEcCtD
Ezetimibe—Palpitations—Doxorubicin—breast cancer	2.39e-05	0.000179	CcSEcCtD
Ezetimibe—Anaphylactic shock—Epirubicin—breast cancer	2.39e-05	0.000178	CcSEcCtD
Ezetimibe—Infection—Epirubicin—breast cancer	2.37e-05	0.000177	CcSEcCtD
Ezetimibe—Cough—Doxorubicin—breast cancer	2.36e-05	0.000176	CcSEcCtD
Ezetimibe—Diarrhoea—Capecitabine—breast cancer	2.34e-05	0.000175	CcSEcCtD
Ezetimibe—Nervous system disorder—Epirubicin—breast cancer	2.34e-05	0.000175	CcSEcCtD
Ezetimibe—Dizziness—Docetaxel—breast cancer	2.34e-05	0.000175	CcSEcCtD
Ezetimibe—Thrombocytopenia—Epirubicin—breast cancer	2.34e-05	0.000175	CcSEcCtD
Ezetimibe—Hypertension—Doxorubicin—breast cancer	2.34e-05	0.000175	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Methotrexate—breast cancer	2.32e-05	0.000174	CcSEcCtD
Ezetimibe—Skin disorder—Epirubicin—breast cancer	2.32e-05	0.000173	CcSEcCtD
Ezetimibe—Insomnia—Methotrexate—breast cancer	2.31e-05	0.000172	CcSEcCtD
Ezetimibe—Arthralgia—Doxorubicin—breast cancer	2.3e-05	0.000172	CcSEcCtD
Ezetimibe—Myalgia—Doxorubicin—breast cancer	2.3e-05	0.000172	CcSEcCtD
Ezetimibe—Chest pain—Doxorubicin—breast cancer	2.3e-05	0.000172	CcSEcCtD
Ezetimibe—Paraesthesia—Methotrexate—breast cancer	2.29e-05	0.000171	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.29e-05	0.000171	CcSEcCtD
Ezetimibe—Discomfort—Doxorubicin—breast cancer	2.27e-05	0.00017	CcSEcCtD
Ezetimibe—Dyspnoea—Methotrexate—breast cancer	2.27e-05	0.00017	CcSEcCtD
Ezetimibe—Dizziness—Capecitabine—breast cancer	2.26e-05	0.000169	CcSEcCtD
Ezetimibe—Dry mouth—Doxorubicin—breast cancer	2.25e-05	0.000168	CcSEcCtD
Ezetimibe—Vomiting—Docetaxel—breast cancer	2.25e-05	0.000168	CcSEcCtD
Ezetimibe—Dyspepsia—Methotrexate—breast cancer	2.24e-05	0.000168	CcSEcCtD
Ezetimibe—Rash—Docetaxel—breast cancer	2.23e-05	0.000167	CcSEcCtD
Ezetimibe—Dermatitis—Docetaxel—breast cancer	2.23e-05	0.000167	CcSEcCtD
Ezetimibe—Confusional state—Doxorubicin—breast cancer	2.23e-05	0.000166	CcSEcCtD
Ezetimibe—Decreased appetite—Methotrexate—breast cancer	2.22e-05	0.000166	CcSEcCtD
Ezetimibe—Headache—Docetaxel—breast cancer	2.22e-05	0.000166	CcSEcCtD
Ezetimibe—Anaphylactic shock—Doxorubicin—breast cancer	2.21e-05	0.000165	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Methotrexate—breast cancer	2.2e-05	0.000165	CcSEcCtD
Ezetimibe—Fatigue—Methotrexate—breast cancer	2.2e-05	0.000164	CcSEcCtD
Ezetimibe—Infection—Doxorubicin—breast cancer	2.19e-05	0.000164	CcSEcCtD
Ezetimibe—Pain—Methotrexate—breast cancer	2.18e-05	0.000163	CcSEcCtD
Ezetimibe—Vomiting—Capecitabine—breast cancer	2.18e-05	0.000163	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Epirubicin—breast cancer	2.17e-05	0.000163	CcSEcCtD
Ezetimibe—Nervous system disorder—Doxorubicin—breast cancer	2.16e-05	0.000162	CcSEcCtD
Ezetimibe—Thrombocytopenia—Doxorubicin—breast cancer	2.16e-05	0.000162	CcSEcCtD
Ezetimibe—Rash—Capecitabine—breast cancer	2.16e-05	0.000161	CcSEcCtD
Ezetimibe—Insomnia—Epirubicin—breast cancer	2.16e-05	0.000161	CcSEcCtD
Ezetimibe—Dermatitis—Capecitabine—breast cancer	2.16e-05	0.000161	CcSEcCtD
Ezetimibe—Headache—Capecitabine—breast cancer	2.15e-05	0.00016	CcSEcCtD
Ezetimibe—Skin disorder—Doxorubicin—breast cancer	2.14e-05	0.00016	CcSEcCtD
Ezetimibe—Paraesthesia—Epirubicin—breast cancer	2.14e-05	0.00016	CcSEcCtD
Ezetimibe—Dyspnoea—Epirubicin—breast cancer	2.13e-05	0.000159	CcSEcCtD
Ezetimibe—Nausea—Docetaxel—breast cancer	2.1e-05	0.000157	CcSEcCtD
Ezetimibe—Feeling abnormal—Methotrexate—breast cancer	2.1e-05	0.000157	CcSEcCtD
Ezetimibe—Dyspepsia—Epirubicin—breast cancer	2.1e-05	0.000157	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Methotrexate—breast cancer	2.08e-05	0.000156	CcSEcCtD
Ezetimibe—Decreased appetite—Epirubicin—breast cancer	2.07e-05	0.000155	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Epirubicin—breast cancer	2.06e-05	0.000154	CcSEcCtD
Ezetimibe—Fatigue—Epirubicin—breast cancer	2.06e-05	0.000154	CcSEcCtD
Ezetimibe—Pain—Epirubicin—breast cancer	2.04e-05	0.000153	CcSEcCtD
Ezetimibe—Constipation—Epirubicin—breast cancer	2.04e-05	0.000153	CcSEcCtD
Ezetimibe—Nausea—Capecitabine—breast cancer	2.03e-05	0.000152	CcSEcCtD
Ezetimibe—Urticaria—Methotrexate—breast cancer	2.03e-05	0.000151	CcSEcCtD
Ezetimibe—Abdominal pain—Methotrexate—breast cancer	2.02e-05	0.000151	CcSEcCtD
Ezetimibe—Body temperature increased—Methotrexate—breast cancer	2.02e-05	0.000151	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.01e-05	0.00015	CcSEcCtD
Ezetimibe—Insomnia—Doxorubicin—breast cancer	2e-05	0.000149	CcSEcCtD
Ezetimibe—Paraesthesia—Doxorubicin—breast cancer	1.98e-05	0.000148	CcSEcCtD
Ezetimibe—Dyspnoea—Doxorubicin—breast cancer	1.97e-05	0.000147	CcSEcCtD
Ezetimibe—Feeling abnormal—Epirubicin—breast cancer	1.97e-05	0.000147	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Epirubicin—breast cancer	1.95e-05	0.000146	CcSEcCtD
Ezetimibe—Dyspepsia—Doxorubicin—breast cancer	1.94e-05	0.000145	CcSEcCtD
Ezetimibe—Decreased appetite—Doxorubicin—breast cancer	1.92e-05	0.000143	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Doxorubicin—breast cancer	1.91e-05	0.000142	CcSEcCtD
Ezetimibe—Fatigue—Doxorubicin—breast cancer	1.9e-05	0.000142	CcSEcCtD
Ezetimibe—Urticaria—Epirubicin—breast cancer	1.9e-05	0.000142	CcSEcCtD
Ezetimibe—Pain—Doxorubicin—breast cancer	1.89e-05	0.000141	CcSEcCtD
Ezetimibe—Constipation—Doxorubicin—breast cancer	1.89e-05	0.000141	CcSEcCtD
Ezetimibe—Abdominal pain—Epirubicin—breast cancer	1.89e-05	0.000141	CcSEcCtD
Ezetimibe—Body temperature increased—Epirubicin—breast cancer	1.89e-05	0.000141	CcSEcCtD
Ezetimibe—Hypersensitivity—Methotrexate—breast cancer	1.88e-05	0.00014	CcSEcCtD
Ezetimibe—Asthenia—Methotrexate—breast cancer	1.83e-05	0.000137	CcSEcCtD
Ezetimibe—Feeling abnormal—Doxorubicin—breast cancer	1.82e-05	0.000136	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Doxorubicin—breast cancer	1.8e-05	0.000135	CcSEcCtD
Ezetimibe—Pruritus—Methotrexate—breast cancer	1.8e-05	0.000135	CcSEcCtD
Ezetimibe—Hypersensitivity—Epirubicin—breast cancer	1.76e-05	0.000131	CcSEcCtD
Ezetimibe—Urticaria—Doxorubicin—breast cancer	1.75e-05	0.000131	CcSEcCtD
Ezetimibe—Abdominal pain—Doxorubicin—breast cancer	1.74e-05	0.00013	CcSEcCtD
Ezetimibe—Body temperature increased—Doxorubicin—breast cancer	1.74e-05	0.00013	CcSEcCtD
Ezetimibe—Diarrhoea—Methotrexate—breast cancer	1.74e-05	0.00013	CcSEcCtD
Ezetimibe—Asthenia—Epirubicin—breast cancer	1.71e-05	0.000128	CcSEcCtD
Ezetimibe—Pruritus—Epirubicin—breast cancer	1.69e-05	0.000126	CcSEcCtD
Ezetimibe—Dizziness—Methotrexate—breast cancer	1.69e-05	0.000126	CcSEcCtD
Ezetimibe—Diarrhoea—Epirubicin—breast cancer	1.63e-05	0.000122	CcSEcCtD
Ezetimibe—Hypersensitivity—Doxorubicin—breast cancer	1.63e-05	0.000122	CcSEcCtD
Ezetimibe—Vomiting—Methotrexate—breast cancer	1.62e-05	0.000121	CcSEcCtD
Ezetimibe—Rash—Methotrexate—breast cancer	1.61e-05	0.00012	CcSEcCtD
Ezetimibe—Dermatitis—Methotrexate—breast cancer	1.61e-05	0.00012	CcSEcCtD
Ezetimibe—Headache—Methotrexate—breast cancer	1.6e-05	0.000119	CcSEcCtD
Ezetimibe—Asthenia—Doxorubicin—breast cancer	1.58e-05	0.000118	CcSEcCtD
Ezetimibe—Dizziness—Epirubicin—breast cancer	1.58e-05	0.000118	CcSEcCtD
Ezetimibe—Pruritus—Doxorubicin—breast cancer	1.56e-05	0.000117	CcSEcCtD
Ezetimibe—Vomiting—Epirubicin—breast cancer	1.52e-05	0.000113	CcSEcCtD
Ezetimibe—Nausea—Methotrexate—breast cancer	1.51e-05	0.000113	CcSEcCtD
Ezetimibe—Diarrhoea—Doxorubicin—breast cancer	1.51e-05	0.000113	CcSEcCtD
Ezetimibe—Rash—Epirubicin—breast cancer	1.5e-05	0.000112	CcSEcCtD
Ezetimibe—Dermatitis—Epirubicin—breast cancer	1.5e-05	0.000112	CcSEcCtD
Ezetimibe—Headache—Epirubicin—breast cancer	1.49e-05	0.000112	CcSEcCtD
Ezetimibe—Dizziness—Doxorubicin—breast cancer	1.46e-05	0.000109	CcSEcCtD
Ezetimibe—Nausea—Epirubicin—breast cancer	1.42e-05	0.000106	CcSEcCtD
Ezetimibe—Vomiting—Doxorubicin—breast cancer	1.4e-05	0.000105	CcSEcCtD
Ezetimibe—Rash—Doxorubicin—breast cancer	1.39e-05	0.000104	CcSEcCtD
Ezetimibe—Dermatitis—Doxorubicin—breast cancer	1.39e-05	0.000104	CcSEcCtD
Ezetimibe—Headache—Doxorubicin—breast cancer	1.38e-05	0.000103	CcSEcCtD
Ezetimibe—Nausea—Doxorubicin—breast cancer	1.31e-05	9.8e-05	CcSEcCtD
Ezetimibe—UGT1A1—Metabolism—TYMS—breast cancer	2.85e-06	2.69e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.85e-06	2.69e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	2.84e-06	2.68e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	2.84e-06	2.68e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CAV1—breast cancer	2.83e-06	2.67e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CAV1—breast cancer	2.83e-06	2.67e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—COMT—breast cancer	2.83e-06	2.67e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PLA2G4A—breast cancer	2.82e-06	2.66e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTM1—breast cancer	2.82e-06	2.66e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NCOR1—breast cancer	2.82e-06	2.66e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CA9—breast cancer	2.82e-06	2.66e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTA4—breast cancer	2.82e-06	2.66e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—STK11—breast cancer	2.81e-06	2.66e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP19A1—breast cancer	2.81e-06	2.66e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTP1—breast cancer	2.81e-06	2.66e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	2.78e-06	2.63e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—HMOX1—breast cancer	2.77e-06	2.62e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ITPR1—breast cancer	2.77e-06	2.61e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTA2—breast cancer	2.75e-06	2.59e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GPX2—breast cancer	2.75e-06	2.59e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SULT1A1—breast cancer	2.71e-06	2.56e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GPX4—breast cancer	2.71e-06	2.56e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.7e-06	2.55e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GPX1—breast cancer	2.7e-06	2.55e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SHMT1—breast cancer	2.69e-06	2.54e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CDA—breast cancer	2.69e-06	2.54e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP1A1—breast cancer	2.67e-06	2.52e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CD—breast cancer	2.66e-06	2.52e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ABCB1—breast cancer	2.66e-06	2.51e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ERCC2—breast cancer	2.65e-06	2.5e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—IDH1—breast cancer	2.65e-06	2.5e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTA1—breast cancer	2.65e-06	2.5e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	2.65e-06	2.5e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CA—breast cancer	2.64e-06	2.5e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ALB—breast cancer	2.63e-06	2.48e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	2.63e-06	2.48e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NAT2—breast cancer	2.62e-06	2.47e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—COMT—breast cancer	2.62e-06	2.47e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TYMS—breast cancer	2.61e-06	2.47e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTP1—breast cancer	2.6e-06	2.46e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC2A5—breast cancer	2.59e-06	2.45e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLCO1B1—breast cancer	2.59e-06	2.45e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PLA2G4A—breast cancer	2.58e-06	2.44e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTM1—breast cancer	2.58e-06	2.44e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NCOR1—breast cancer	2.58e-06	2.44e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CG—breast cancer	2.58e-06	2.43e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CG—breast cancer	2.58e-06	2.43e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—HMOX1—breast cancer	2.57e-06	2.43e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ITPR1—breast cancer	2.56e-06	2.42e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NOS3—breast cancer	2.52e-06	2.38e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APRT—breast cancer	2.5e-06	2.37e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MTHFR—breast cancer	2.49e-06	2.35e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GPX1—breast cancer	2.48e-06	2.34e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ABCB1—breast cancer	2.47e-06	2.33e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP1A1—breast cancer	2.45e-06	2.31e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ERCC2—breast cancer	2.43e-06	2.29e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TYMS—breast cancer	2.42e-06	2.29e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	2.41e-06	2.28e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NCOR1—breast cancer	2.39e-06	2.26e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PLA2G4A—breast cancer	2.39e-06	2.26e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTM1—breast cancer	2.39e-06	2.26e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ESRRA—breast cancer	2.35e-06	2.22e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ANGPTL4—breast cancer	2.35e-06	2.22e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	2.33e-06	2.2e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CB—breast cancer	2.32e-06	2.19e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—breast cancer	2.3e-06	2.17e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CAV1—breast cancer	2.3e-06	2.17e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—DPYD—breast cancer	2.3e-06	2.17e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MED12—breast cancer	2.3e-06	2.17e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GPX1—breast cancer	2.29e-06	2.16e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MTHFR—breast cancer	2.28e-06	2.16e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP1A1—breast cancer	2.27e-06	2.14e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CD—breast cancer	2.27e-06	2.14e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CD—breast cancer	2.27e-06	2.14e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALDOA—breast cancer	2.26e-06	2.14e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ERCC2—breast cancer	2.25e-06	2.12e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ALB—breast cancer	2.24e-06	2.11e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ALB—breast cancer	2.24e-06	2.11e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GPI—breast cancer	2.23e-06	2.11e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HADHB—breast cancer	2.23e-06	2.11e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NCOA3—breast cancer	2.2e-06	2.07e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC2A2—breast cancer	2.18e-06	2.06e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKT1—breast cancer	2.16e-06	2.04e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NOS3—breast cancer	2.14e-06	2.02e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NOS3—breast cancer	2.14e-06	2.02e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CPT1A—breast cancer	2.14e-06	2.02e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ABCG2—breast cancer	2.14e-06	2.02e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MTR—breast cancer	2.14e-06	2.02e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALDH7A1—breast cancer	2.13e-06	2.01e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALDH1A1—breast cancer	2.13e-06	2.01e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MTHFR—breast cancer	2.12e-06	2e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CAV1—breast cancer	2.11e-06	1.99e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CG—breast cancer	2.09e-06	1.98e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HPGDS—breast cancer	2.09e-06	1.98e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HBA1—breast cancer	2.08e-06	1.97e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—FHL2—breast cancer	2.04e-06	1.93e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NME1—breast cancer	2.04e-06	1.93e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ADSL—breast cancer	2.04e-06	1.93e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PHGDH—breast cancer	2.04e-06	1.93e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—UMPS—breast cancer	2.04e-06	1.93e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTT1—breast cancer	2.03e-06	1.92e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ACHE—breast cancer	2.03e-06	1.92e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.01e-06	1.9e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTEN—breast cancer	2.01e-06	1.9e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HPSE—breast cancer	2e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—BRIP1—breast cancer	2e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LDHB—breast cancer	2e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CB—breast cancer	1.97e-06	1.86e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CB—breast cancer	1.97e-06	1.86e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.97e-06	1.86e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—breast cancer	1.96e-06	1.85e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—breast cancer	1.96e-06	1.85e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CAV1—breast cancer	1.95e-06	1.84e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP17A1—breast cancer	1.92e-06	1.82e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CG—breast cancer	1.92e-06	1.81e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ENO1—breast cancer	1.9e-06	1.8e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS1—breast cancer	1.9e-06	1.8e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCC1—breast cancer	1.9e-06	1.79e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTA3—breast cancer	1.9e-06	1.79e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HMMR—breast cancer	1.9e-06	1.79e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2D6—breast cancer	1.87e-06	1.76e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CD—breast cancer	1.84e-06	1.74e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPARGC1B—breast cancer	1.84e-06	1.74e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NCOA2—breast cancer	1.83e-06	1.73e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ALB—breast cancer	1.82e-06	1.72e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	1.78e-06	1.68e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—FASN—breast cancer	1.78e-06	1.68e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CG—breast cancer	1.78e-06	1.68e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—BCHE—breast cancer	1.77e-06	1.67e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC5A5—breast cancer	1.75e-06	1.65e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NOS3—breast cancer	1.74e-06	1.64e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CA9—breast cancer	1.74e-06	1.64e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTA4—breast cancer	1.74e-06	1.64e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTEN—breast cancer	1.71e-06	1.61e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTEN—breast cancer	1.71e-06	1.61e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GPX2—breast cancer	1.69e-06	1.6e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTA2—breast cancer	1.69e-06	1.6e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC2A1—breast cancer	1.69e-06	1.59e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NQO1—breast cancer	1.69e-06	1.59e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CD—breast cancer	1.69e-06	1.59e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GPX4—breast cancer	1.67e-06	1.58e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SULT1A1—breast cancer	1.67e-06	1.58e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ALB—breast cancer	1.67e-06	1.57e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP3A4—breast cancer	1.65e-06	1.55e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—IDH1—breast cancer	1.63e-06	1.54e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTA1—breast cancer	1.63e-06	1.54e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP1B1—breast cancer	1.62e-06	1.53e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NAT2—breast cancer	1.61e-06	1.52e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.61e-06	1.52e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CB—breast cancer	1.6e-06	1.52e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NOS3—breast cancer	1.59e-06	1.5e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—breast cancer	1.59e-06	1.5e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HSP90AA1—breast cancer	1.59e-06	1.5e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CD—breast cancer	1.56e-06	1.48e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NCOA1—breast cancer	1.54e-06	1.46e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ALB—breast cancer	1.54e-06	1.46e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—STK11—breast cancer	1.52e-06	1.44e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP19A1—breast cancer	1.52e-06	1.44e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NOS3—breast cancer	1.48e-06	1.39e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CB—breast cancer	1.47e-06	1.39e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—breast cancer	1.46e-06	1.38e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CA—breast cancer	1.42e-06	1.34e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MED12—breast cancer	1.42e-06	1.34e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—DPYD—breast cancer	1.42e-06	1.34e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—COMT—breast cancer	1.41e-06	1.34e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTP1—breast cancer	1.41e-06	1.33e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALDOA—breast cancer	1.39e-06	1.32e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HMOX1—breast cancer	1.39e-06	1.31e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTEN—breast cancer	1.39e-06	1.31e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ITPR1—breast cancer	1.39e-06	1.31e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CB—breast cancer	1.36e-06	1.29e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NCOA3—breast cancer	1.35e-06	1.28e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—breast cancer	1.35e-06	1.27e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC2A2—breast cancer	1.34e-06	1.27e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MTR—breast cancer	1.32e-06	1.24e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCG2—breast cancer	1.32e-06	1.24e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CPT1A—breast cancer	1.32e-06	1.24e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TYMS—breast cancer	1.31e-06	1.24e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PLA2G4A—breast cancer	1.29e-06	1.22e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTM1—breast cancer	1.29e-06	1.22e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NCOR1—breast cancer	1.29e-06	1.22e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HPGDS—breast cancer	1.29e-06	1.22e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HBA1—breast cancer	1.28e-06	1.21e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTEN—breast cancer	1.27e-06	1.2e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ACHE—breast cancer	1.25e-06	1.18e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTT1—breast cancer	1.25e-06	1.18e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GPX1—breast cancer	1.24e-06	1.17e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP1A1—breast cancer	1.23e-06	1.16e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ERCC2—breast cancer	1.22e-06	1.15e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CA—breast cancer	1.2e-06	1.14e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CA—breast cancer	1.2e-06	1.14e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP17A1—breast cancer	1.18e-06	1.12e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTEN—breast cancer	1.18e-06	1.11e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS1—breast cancer	1.17e-06	1.11e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ENO1—breast cancer	1.17e-06	1.11e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKT1—breast cancer	1.16e-06	1.09e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2D6—breast cancer	1.15e-06	1.09e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MTHFR—breast cancer	1.14e-06	1.08e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NCOA2—breast cancer	1.13e-06	1.07e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—FASN—breast cancer	1.09e-06	1.03e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—BCHE—breast cancer	1.09e-06	1.03e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC5A5—breast cancer	1.08e-06	1.02e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CAV1—breast cancer	1.05e-06	9.96e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC2A1—breast cancer	1.04e-06	9.82e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NQO1—breast cancer	1.04e-06	9.82e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP1B1—breast cancer	9.97e-07	9.42e-06	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKT1—breast cancer	9.83e-07	9.29e-06	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKT1—breast cancer	9.83e-07	9.29e-06	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CA—breast cancer	9.78e-07	9.24e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HSP90AA1—breast cancer	9.78e-07	9.23e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CG—breast cancer	9.61e-07	9.07e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NCOA1—breast cancer	9.51e-07	8.98e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—STK11—breast cancer	9.38e-07	8.85e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP19A1—breast cancer	9.38e-07	8.85e-06	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CA—breast cancer	8.96e-07	8.47e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—COMT—breast cancer	8.72e-07	8.23e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTP1—breast cancer	8.67e-07	8.19e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HMOX1—breast cancer	8.56e-07	8.08e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ITPR1—breast cancer	8.54e-07	8.06e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CD—breast cancer	8.45e-07	7.98e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALB—breast cancer	8.34e-07	7.87e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CA—breast cancer	8.3e-07	7.84e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCB1—breast cancer	8.21e-07	7.75e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TYMS—breast cancer	8.06e-07	7.62e-06	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKT1—breast cancer	7.99e-07	7.55e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NOS3—breast cancer	7.98e-07	7.53e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PLA2G4A—breast cancer	7.97e-07	7.53e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NCOR1—breast cancer	7.97e-07	7.53e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTM1—breast cancer	7.97e-07	7.53e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GPX1—breast cancer	7.63e-07	7.21e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP1A1—breast cancer	7.56e-07	7.14e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ERCC2—breast cancer	7.49e-07	7.08e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CB—breast cancer	7.36e-07	6.95e-06	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKT1—breast cancer	7.32e-07	6.92e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—breast cancer	7.29e-07	6.89e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MTHFR—breast cancer	7.05e-07	6.65e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKT1—breast cancer	6.78e-07	6.4e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CAV1—breast cancer	6.5e-07	6.14e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTEN—breast cancer	6.36e-07	6.01e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CG—breast cancer	5.92e-07	5.59e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CD—breast cancer	5.2e-07	4.91e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALB—breast cancer	5.14e-07	4.85e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NOS3—breast cancer	4.91e-07	4.64e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CB—breast cancer	4.54e-07	4.28e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—breast cancer	4.49e-07	4.24e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CA—breast cancer	4.49e-07	4.24e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTEN—breast cancer	3.92e-07	3.7e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKT1—breast cancer	3.67e-07	3.46e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CA—breast cancer	2.76e-07	2.61e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKT1—breast cancer	2.26e-07	2.13e-06	CbGpPWpGaD
